Frank Dimaio, MD
Adult Reconstructive Orthopaedic Surgery · Garden City, NYNPI 1275532988
Payments from drug & device makers
What this record shows
This record is dominated by royalties or licence payments: $110,550 of the $148,955 with a category attached, or 74.2%. Zimmer Biomet accounts for 99.7% of it on its own, with 10 other manufacturers making up the rest. 2025 is the largest year on record at $76,435, more than ten times the $160 reported in 2019.
Across 95 payments — averaging $1567.95 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Zimmer Biomet$148K
- Abbott$113
- Lima USA, Inc.$93
- Johnson & Johnson$89
- Ortho Systems$61
- Stryker$25
- plus $83 from 5 others
Across 20 payments — averaging $11,110 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Zimmer Biomet$222K
What the payments were for
- Royalty or licence$110,55074%
- Consulting fees$33,00222%
- Travel & lodging$2,3732%
- Food & beverage$2,5562%
- Education$4740%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Zimmer Biomet | 82 | $148,491 |
| Abbott | 1 | $113 |
| Lima USA, Inc. | 1 | $93 |
| Johnson & Johnson | 4 | $89 |
| Ortho Systems | 1 | $61 |
| Stryker | 1 | $25 |
| Total Joint Orthopedics, Inc. | 1 | $20 |
| Merck | 1 | $17 |
| Corin USA | 1 | $16 |
| Bioventus LLC | 1 | $15 |
| Amgen | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Persona$81,393
- Persona The Personalized Knee OsseoTi$31,453
- PD-Knee-New Product$12,358
- Avenir$473
- ROSA$377
- ECHO PRESS-FIT HIP SYSTEM$187
- RELIGN$137
- Arcos$127
- Proclaim IPG$113
- Persona Revision$109
- ROSA-Knee$101
How this compares
$148,955 in reported general payments places this provider in the 80th percentile of 85 adult reconstructive orthopaedic surgery providers in New York.
See all adult reconstructive orthopaedic surgery providers in New York →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Naproxen | 72 | $1,035 |
| Meloxicam | 85 | $452 |
| Methylprednisolone | 64 | $441 |
| Amoxicillin | 60 | $368 |
| Diclofenac Sodium | 14 | $235 |
| Clindamycin Hcl | 13 | $71 |
Paid to pharmacies, not to this prescriber.
Other adult reconstructive orthopaedic surgery in Garden City
- Patrick LeungGarden City$8K
- Seth JerabekNew York$7.1M
- Jose RodriguezNew York$3.4M
- Friedrich BoettnerNew York$2.9M
- Jonathan VigdorchikNew York$2.3M
- William LongNew York$1.5M
- Peter SculcoNew York$1.5M
- Roshan ShahNew York$1.3M
- Herbert CooperNew York$1.3M
- Matthew AustinNew York$986K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.